131: Exam 1

IIV3

alfuria, fluarix, fluzone, flulaval

ccIIV3

flucelvax

RIV3

flublok

LAIV3

flumist

allV3

fluad

HD-IIV3

fluzone high dose

PPSV-23

pneumovax

PCV15

VAXNEUVANCE

PCV20

prevnar

PCV21

capvaxive

mAB

nirsevimab, clesrovimab

RSVPreF3

arexyvy

mRNA (RSV)

mRESVIA

RSVPreF

abrysvo

mRNA (Covid-19)

pfizer, SPIKEVAX, mNEXSPIKE

protein based (Covid-19)

NUVAXOVID

DTaP

daptacel, infanrix

Tdap

adacel, boostrix

aluminum

engerix-B, recombivax HB

synthetic

heplisav-B

AS01B

shringrix

live (shingles)

zostavax

influenza dosage

2 dose - 6mo-8yr [0,1mo] + 1 dose/year (sept-oct)

influenza redose age (healthy adults, without immunocompromising conditions or increased risk)

65 yr

pneumococcal dosage

4 doses [2,4,6,12-15mo] + 1 dose [old]

pneumococcal redose age (healthy adults, without immunocompromising conditions or increased risk)

50 yr

RSV dosage

mother: 1 dose [32-36 wk] (sept-jan) - ONCE FOR LIFE

newborn: @RSV 1 dose 0-1wk, @not RSV 1 dose before next RSV

old: 1 dose >75, 50-74** (aug-oct)

RSV redose age (healthy adults, without immunocompromising conditions or increased risk)

75 yr

Covid-19 dosage

2 doses (6-23 mo) [0,1 mo] + 1 dose/year (2-64 yr) + 2 doses/year (>65) [0,6 mo]

Covid-19 redose age (healthy adults, without immunocompromising conditions or increased risk)

65 yr

tetanus, diphtheria, pertussis dosage

DTap: 5 doses [2,4,6,15-18mo, 4-6yr]

+Tdap: 1 dose/10 years (>65) or (10-64 yr if preg 27-36 wk, wound, cocooning) - EVERY PREGNANCY

tetanus, diphtheria, pertussis redose age (healthy adults, without immunocompromising conditions or increased risk)

65 yr

Hepatitis B dosage

baby: 3 doses [0,1-2,6-18 mo]

5-59yr no vax or no immunity + old (>60), diabetes, dialysis : 2 dose [0,1mo] OR 3 dose [0,1,5nmo]

Hepatitis B redose age (healthy adults, without immunocompromising conditions or increased risk)

60 yr

Shingles dosage

2 dose: >50 or zostavax or nothing [0,2-6mo]

2 dose: >19** [0,1-2 mo]

shingles redose age (healthy adults, without immunocompromising conditions or increased risk)

50 yr

MMR dosage

2 dose: [12-15mo, 4-6 yr]
if no immunity: 1 dose low risk OR 2 dose high risk [0, 1mo]

Varicella dosage

2 dose [12-15 mo SEIZURE, 4-6 yr]

if no immunity: 2 doses (7-12 yo) [0,3 mo], (>13 yo) : 2 doses [0,4-8wk]

HPV dosage

9-14 yo: 2 doses [0,6-12mo], if ** then 3 doses [0,1-2, 6-12mo]

15-45 yo: [0,1-2,6mo]

Hepatitis A dosage

1-2yo: 2 dose [0,6 mo]

+2 dose (@risk HIV, gay, travel) [0,6 mo]

poliomyelitis dosage

IPV: 4 doses [2,4,6-18mo, 4-6 yr]

tOPV: +1 dose if **

MPOX dosage

>18 yo: 2 doses [0, 1mo]

Haemophilus Influenza dosage

1) PRP-T: 3 dose [2,4,6 mo] + 1 booster [12-15mo] ** SCT

2) PRP-OMP: 2 dose [2,4mo] + 1 booster [12-15mo]

rotavirus dosage

6-32wk old

1) RV5: 3 dose [2,4,6mo] 2mL

2) FV1: 2 dose [2,4mo] 1mL

Meningococcal dosage

ACWY

<7** [0,3yr]

11-12 yo: 1 dose + 16 yo: 1 booster

if had nothing by 16yo, 19-21: 1 dose

adult**: [0,5yr]

Men B

16-23 yo: 2 doses [0,6 mo]

>10**: 2 doses [0,6] + booster [1 yr later] + booster * 1 yr OR ** 6 mo later

ABCWY

16-23 yo: 2 doses [0,6mo]

>10 **: 2 doses [0,6mo]